Holds a game-changing platform exploiting protein-conformation dynamics to discover next generation GPCR drugs devoid of on-target side effects once thought to be unavoidable.
Active Portfolio Company
www.mebiasdiscovery.com
Total raised: $3.5M
Investors 1
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.10.2019 | - | $3.5M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 14.10.2019 | Mebias Discovery Closes $3.5M Funding Round | Mebias Discovery, a Philadelphia, PA-based leader in the field of drug discovery targeting G-protein... | finsmes.co... |
| - | Mebias Discovery | “Home - Mebias-Discovery” | fastfounde... |